ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

CTO Tclarke Plc

162.50
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Tclarke Plc LSE:CTO London Ordinary Share GB0002015021 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 162.50 162.00 162.50 164.50 162.00 163.00 292,199 16:35:05
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Special Trade Contractor,nec 491M 6.5M 0.1230 13.17 85.62M
Tclarke Plc is listed in the Special Trade Contractor sector of the London Stock Exchange with ticker CTO. The last closing price for Tclarke was 162.50p. Over the last year, Tclarke shares have traded in a share price range of 105.00p to 164.50p.

Tclarke currently has 52,850,780 shares in issue. The market capitalisation of Tclarke is £85.62 million. Tclarke has a price to earnings ratio (PE ratio) of 13.17.

Tclarke Share Discussion Threads

Showing 4901 to 4924 of 5125 messages
Chat Pages: 205  204  203  202  201  200  199  198  197  196  195  194  Older
DateSubjectAuthorDiscuss
07/3/2023
15:40
Results tomorrow...
igoe104
31/1/2023
18:47
What are you going to wear?
rbewes
31/1/2023
09:48
The company are doing a zoom webinaer on the 9th March. I've just had my invite.
igoe104
26/1/2023
08:26
Cenkos note update.
igoe104
26/1/2023
08:15
TClarke PLC Trading Statement
johnwise
26/1/2023
08:00
agree looks pretty positive and unfortunateky you are probably right muckshifter
janeann
26/1/2023
07:16
Everything looks good to me. 👍
igoe104
24/11/2022
11:48
If 40 million of revenue has been forwarded to 2023, it will be difficult to see a 18% drop in 2023. Especially when they are forecasting at least 500 Million revenue.🤷
igoe104
24/11/2022
09:54
Where the link for 18% reduction for next year ?
igoe104
24/11/2022
09:27
Agree Dr B..

toswas I hadn't seen that they were reducing 2023 numbers.

edmundshaw
24/11/2022
08:59
I get a bit fed up with companies saying orders retimed/reprogrammed into next year. It’s a miss. Otherwise the target should be 540m for next year.

Having said that, if they can deliver £14m next year(2.8*500m) then the shares are cheap with a 50m mkt cap

dr biotech
24/11/2022
08:41
Agree with most of that edmund but not just a timing issue when the house broker is reducing numbers by 11% this year and 18.5% next!
tiswas
24/11/2022
08:18
In reality its a big profit warning IMO. Its all down to personal opinion whether its in the price or not.
spooky
24/11/2022
08:17
Took my numbers from Stockopedia. Will revert to Cenkos numbers. However business is in good shape with a decent yield imo
aishah
24/11/2022
08:13
FY 23 eps forecast down 18.5% from 24.2p to 19.7p
phar lap
24/11/2022
08:13
No idea where you get your numbers from Aishah. Cenkos forecasting adjusted eps of 19p for '22, down 11%.
tiswas
24/11/2022
08:07
The ONLY thing the market seems to be seeing is the:- with some £40m of revenue previously expected to be delivered in 2022 now being reprogrammed into 2023... comment.

Ho hum...

cwa1
24/11/2022
07:57
Snippet from Cenkos research this morning:-

◼ View: The group remains in a very strong position, targeting a balanced and protected order and a balance sheet supportive of its growth ambitions. On revised forecasts, the shares remain inexpensive on a FY23E PE of c.6x and EV/EBITDA of c.3x. With a 4.5% dividend yield and an improving balance sheet providing a further underpin to the equity story, we reiterate our BUY recommendation.

cwa1
24/11/2022
07:54
EPS fcst of 25.65p though with the 27% uplift. Analyst consensus was 21.2p
aishah
24/11/2022
07:23
The trouble is that they were expecting £450m for 2022 and £500m for 2023, but £40m has moved into 2023, leaving 2022 at £410m and 2023 the same. Looks like EBIT will be £1m less than forecasts
18bt
24/11/2022
07:19
Confident trading update:
"2022 is expected to be the first time Group revenues have exceeded £400 million. Operating margins (EBIT) are anticipated to be circa 2.8%.

As a result of this strong performance, the Group's earnings per share are expected to rise by approximately 27% in 2022 when compared to the prior year.

The Group remains on track to deliver £500m revenues in 2023."

"We are currently tendering in excess of £1bn of opportunities and are expecting decisions on approximately £500m of tendered projects by early 2023."

aishah
02/11/2022
11:44
Not a fan of low margin contractor businesses, but this is a well run outfit with good discipline on contract negotiation/pricing risk.

52m M.cap, low PE and supporting positive outlook statements. Looking attractive IMO

owenski
23/9/2022
14:13
Interesting the 5k I added this morning showed as a sell, and the next 2.5k bought about half an hour ago not showing yet Looks like I am not the only 'Bargain Hunter' here :)
santangello
23/9/2022
14:10
Interesting .....the 5k I stole this morning showed as a sell, and the 2.5k bought not long ago, not showing at all.Looks like I am not the only 'Bargain Hunter' here :)
santangello
Chat Pages: 205  204  203  202  201  200  199  198  197  196  195  194  Older

Your Recent History

Delayed Upgrade Clock